Drug Monitoring

"Drug Monitoring" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically.

Descriptor ID	D016903
MeSH Number(s)	E01.370.520.200
Concept/Terms	Drug Monitoring Drug Monitoring Monitoring, Drug Therapeutic Drug Monitoring Therapeutic Drug Monitoring Drug Monitoring, Therapeutic Monitoring, Therapeutic Drug

Below are MeSH descriptors whose meaning is more general than "Drug Monitoring".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Diagnostic Techniques and Procedures [E01.370]
Monitoring, Physiologic [E01.370.520]
Drug Monitoring [E01.370.520.200]

Below are MeSH descriptors whose meaning is related to "Drug Monitoring".

Below are MeSH descriptors whose meaning is more specific than "Drug Monitoring".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Drug Monitoring" by people in this website by year, and whether "Drug Monitoring" was a major or minor topic of these publications.

Bar chart showing 17 publications over 11 distinct years, with a maximum of 3 publications in 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	1	0	1
2009	0	1	1
2011	2	1	3
2012	1	1	2
2014	2	0	2
2015	1	0	1
2016	2	0	2
2018	0	1	1
2019	0	1	1
2020	1	0	1
2025	1	1	2

Below are the most recent publications written about "Drug Monitoring" by people in Profiles.

Wang H, Torres CM, Giordano TP, Dang BN, Liang D. Attitudes and Barriers Toward Antiretroviral Therapeutic Drug Monitoring Among Infectious Disease Providers. Medicina (Kaunas). 2025 Mar 20; 61(3).

View in: PubMed
Asare E, Du T, Xie H, Liang D, Gao S. Biopharmaceutical Factors Involved in the Disposition of Mycophenolic Acid: A Comprehensive Review of ADME Properties and Their Potential Impact on Mycophenolic Acid Plasma Exposure. Curr Drug Metab. 2025; 26(3):159-172.

View in: PubMed
Alonso-Padilla J, Abril M, Alarc?n de Noya B, Almeida IC, Angheben A, Araujo Jorge T, Chatelain E, Esteva M, Gasc?n J, Grijalva MJ, Guhl F, Hasslocher-Moreno AM, L?pez MC, Luquetti A, Noya O, Pinazo MJ, Ramsey JM, Ribeiro I, Ruiz AM, Schijman AG, Sosa-Estani S, Thomas MC, Torrico F, Zrein M, Picado A. Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus. PLoS Negl Trop Dis. 2020 04; 14(4):e0008035.

View in: PubMed
Fitzgerald BL, Islam MN, Graham B, Mahapatra S, Webb K, Boom WH, Malherbe ST, Joloba ML, Johnson JL, Winter J, Walzl G, Belisle JT. Elucidation of a Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy. ACS Infect Dis. 2019 03 08; 5(3):353-364.

View in: PubMed
Min S, Papaz T, Lafreniere-Roula M, Nalli N, Grasemann H, Schwartz SM, Kamath BM, Ng V, Parekh RS, Manlhiot C, Mital S. A randomized clinical trial of age and genotype-guided tacrolimus dosing after pediatric solid organ transplantation. Pediatr Transplant. 2018 11; 22(7):e13285.

View in: PubMed
Han J, Saraf SL, Lash JP, Gordeuk VR. Use of anti-inflammatory analgesics in sickle-cell disease. J Clin Pharm Ther. 2017 Oct; 42(5):656-660.

View in: PubMed
Carris NW, Hwang AY, Smith SM, Taylor JR, Sando K, Powell J, Rosenberg EI, Zumberg MS, Gums JG, Dietrich EA, Anderson KV. Patient satisfaction with extended-interval warfarin monitoring. J Thromb Thrombolysis. 2016 Nov; 42(4):486-93.

View in: PubMed
RoyChoudhury S, Rawat V, Jalal AH, Kale SN, Bhansali S. Recent advances in metamaterial split-ring-resonator circuits as biosensors and therapeutic agents. Biosens Bioelectron. 2016 Dec 15; 86:595-608.

View in: PubMed
Shipkova M, Hesselink DA, Holt DW, Billaud EM, van Gelder T, Kunicki PK, Brunet M, Budde K, Barten MJ, De Simone P, Wieland E, L?pez OM, Masuda S, Seger C, Picard N, Oellerich M, Langman LJ, Wallemacq P, Morris RG, Thompson C, Marquet P. Therapeutic Drug Monitoring of Everolimus: A Consensus Report. Ther Drug Monit. 2016 Apr; 38(2):143-69.

View in: PubMed
Mojtahedzadeh M, Lee ML, Friedman TC. Continuation or discontinuation of pioglitazone when starting bedtime insulin in patients with poorly controlled type 2 diabetes in an inner-city population. J Diabetes Complications. 2015 Nov-Dec; 29(8):1248-52.

View in: PubMed

People

Explore

Similar Concepts

Top Journals